Cargando…
Oral Glucose Tolerance Test: An Informative Endpoint or an Added Burden in Metformin Drug–Drug Interaction Studies?
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540494/ https://www.ncbi.nlm.nih.gov/pubmed/35687738 http://dx.doi.org/10.1002/cpt.2650 |
| _version_ | 1784803718149963776 |
|---|---|
| author | Dauki, Anees M. Hsueh, Chia‐Hsiang Cherala, Ganesh Othman, Ahmed A. |
| author_facet | Dauki, Anees M. Hsueh, Chia‐Hsiang Cherala, Ganesh Othman, Ahmed A. |
| author_sort | Dauki, Anees M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9540494 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95404942022-10-14 Oral Glucose Tolerance Test: An Informative Endpoint or an Added Burden in Metformin Drug–Drug Interaction Studies? Dauki, Anees M. Hsueh, Chia‐Hsiang Cherala, Ganesh Othman, Ahmed A. Clin Pharmacol Ther Perspectives John Wiley and Sons Inc. 2022-06-10 2022-09 /pmc/articles/PMC9540494/ /pubmed/35687738 http://dx.doi.org/10.1002/cpt.2650 Text en © 2022 Gilead Sciences, Inc. Clinical Pharmacology & Therapeutics published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Perspectives Dauki, Anees M. Hsueh, Chia‐Hsiang Cherala, Ganesh Othman, Ahmed A. Oral Glucose Tolerance Test: An Informative Endpoint or an Added Burden in Metformin Drug–Drug Interaction Studies? |
| title | Oral Glucose Tolerance Test: An Informative Endpoint or an Added Burden in Metformin Drug–Drug Interaction Studies? |
| title_full | Oral Glucose Tolerance Test: An Informative Endpoint or an Added Burden in Metformin Drug–Drug Interaction Studies? |
| title_fullStr | Oral Glucose Tolerance Test: An Informative Endpoint or an Added Burden in Metformin Drug–Drug Interaction Studies? |
| title_full_unstemmed | Oral Glucose Tolerance Test: An Informative Endpoint or an Added Burden in Metformin Drug–Drug Interaction Studies? |
| title_short | Oral Glucose Tolerance Test: An Informative Endpoint or an Added Burden in Metformin Drug–Drug Interaction Studies? |
| title_sort | oral glucose tolerance test: an informative endpoint or an added burden in metformin drug–drug interaction studies? |
| topic | Perspectives |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540494/ https://www.ncbi.nlm.nih.gov/pubmed/35687738 http://dx.doi.org/10.1002/cpt.2650 |
| work_keys_str_mv | AT daukianeesm oralglucosetolerancetestaninformativeendpointoranaddedburdeninmetformindrugdruginteractionstudies AT hsuehchiahsiang oralglucosetolerancetestaninformativeendpointoranaddedburdeninmetformindrugdruginteractionstudies AT cheralaganesh oralglucosetolerancetestaninformativeendpointoranaddedburdeninmetformindrugdruginteractionstudies AT othmanahmeda oralglucosetolerancetestaninformativeendpointoranaddedburdeninmetformindrugdruginteractionstudies |